Fzata, Inc.
PrivateLast Round
Grant
Sep 24, 2024
Total Funding Raised
$25M
Company Overview
Fzata, Inc. is a biopharmaceutical company that develops oral live biotherapeutic medicines using its proprietary Bioengineered Probiotic Yeast Medicines (BioPYM™) platform to treat gastrointestinal and gut-brain axis disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fzata, Inc. Comparables
Compare Fzata, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Esperovax | 80% | |
| Precigen | 78% | |
| Sorriso Therapeutics | 76% |
Fzata, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 24, 2024 | ||||
| Series A | Jan 26, 2023 | ||||
| Grant | Jan 15, 2018 |
Fzata, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| TEDCO | Seed |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2024
$7M grant awarded by NINDS
- Mar 28, 2024
Grew 38% QoQ, from 8 to 11 employees.
Fzata, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Fzata, Inc.'s valuation, stock price, and market status.
Is Fzata, Inc. a public or private company?
Fzata, Inc. is a private company.
What is the current stock price of Fzata, Inc.?
Fzata, Inc. is a private company, so its shares have no public market price. Caplight tracks Fzata, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fzata, Inc. worth (valuation)?
Valuation information for Fzata, Inc. is not publicly available.
Can I buy Fzata, Inc. stock?
Fzata, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fzata, Inc.'s last funding round?
Fzata, Inc.'s most recent funding round was Grant on September 24, 2024.
Who are the main investors in Fzata, Inc.?
Key investors in Fzata, Inc. include NIH RADx, National Institute of Neurological Disorders and Stroke (NINDS).
Will Fzata, Inc. IPO soon?
No public IPO plans have been announced for Fzata, Inc..
How can I track Fzata, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Fzata, Inc.'s shares on secondary markets.